Active Lungs & Breathing NIHR-supported project Digestion, Kidneys & Other Organs

DEXACELL: Dexamethasone as an adjunctive therapy for the management of cellulitis- a randomised controlled trial in urgent secondary care

Funder NIHR (part of DHSC)
Recipient organisation NIHR Cambridge Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Jan 2025 — Dec 2026

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Dhakshini Sathasivam (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

DEXACELL: Dexamethasone as an adjunctive therapy for the management of cellulitis - a randomised controlled trial in urgent secondary care
Glucocorticoids in adults with Acute Respiratory Distress Syndrome: Arandomised, parallel-group, allocation-concealed, open label, pragmatic,group sequential design, clinical and cost- effectiveness trial withinternal pilot: GuARDS Trial
Glucocorticoids in adults with Acute Respiratory Distress Syndrome: A randomised, parallel-group, allocationconcealed, open label, pragmatic, group sequential design, clinical and cost- effectiveness trial with internal pilot (GuARDS)
Glucocorticoids in adults with Acute Respiratory Distress Syndrome: A randomised, parallel-group, allocation-concealed, open label, pragmatic, group sequential design, clinical and cost- effectiveness trial with internal pilot: GuARDS Trial
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)

Original classification

Immunity, Inflammation and Transplantation

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.